- 2 hrs ago Ashadha Gupt Navratri 2022: Goddess Skandamata Puja: Date, Rituals, Mantras And Significance
- 2 hrs ago Niti Aayog Releases Compendium Of Ayush Practices To Manage Covid-19
- 3 hrs ago MCD, Jamia Hold Event To Raise Awareness About Controlling Dengue, Other Vector-Borne Diseases
- 9 hrs ago Daily Horoscope, 04 July 2022: Today's Horoscope Predictions For All Zodiac Signs
- Movies Minions: The Rise Of Gru Collects $108.5 Million At The Global Box Office In Debut Weekend
- News Don’t push TN to revive separate state demand: A Raja demands autonomy
- Sports Rahul Dravid Set To Achieve This Rare Record As India Coach Against England At Edgbaston
- Technology Nothing Phone 1 Launching On July 12 In India; Expected Features & Pricing
- Travel Yosemite National Park: A Splendid Wilderness With Magical Sunset And Moonlight
- Finance 1 Mid Cap & 1 Large Cap Banking Stock Turning Ex-Dividend This Week- Should You Buy?
- Education SSC MTS 2021-22 Exam Start Tomorrow: Check Timings, Documents to Carry, Paper Pattern & More
- Automobiles Ultraviolette F77 Updated With Improved Performance & Range: India Launch In A Few Weeks
Vaccines are designed to prevent infection by preparing the body to resist foreign invaders (bacteria, viruses, and other pathogens). In all vaccines, a harmless piece of a particular bacteria or virus is introduced into the body, which produces an immune response. The majority of vaccines consist of weakened or dead microbes or viruses.
However, Messenger RNA (mRNA) vaccines use a molecule instead of a part of an actual bacteria or virus. A messenger RNA is a type of RNA necessary for the production of proteins. A cell's mRNA uses information from genes to create a blueprint for making proteins. As soon as a cell has finished making a protein, it breaks down its mRNA. Vaccine mRNA does not enter the nucleus and does not alter DNA .
This article contains the following:
- How Do mRNA Vaccines Work? What About The Previous mRNA Vaccines?
- When Will The New mRNA Vaccine Be Available In India?
- How Is The New mRNA Vaccine 'Better' Than Others?
- What Are The Benefits Of mRNA Vaccines?
India's First mRNA Vaccine Against COVID-19: What You Need To Know
The Center for Cellular and Molecular Biology (CCMB) has created India's first indigenous mRNA vaccine for COVID-19. The vaccine technology, which is 90 per cent effective against COVID-19 in a mouse model, may also be applied to other infectious diseases, such as malaria, dengue, and tuberculosis .
The new mRNA vaccine candidate is currently being tested for its effectiveness against a live novel Coronavirus infection in a preclinical study.
According to experts, these are the 'benefits' of mRNA vaccines :
- A vaccine that contains mRNA can be effective against malaria or dengue
- mRNA vaccines are more cost-effective
- mRNA vaccine is promptly redesigned
How Do mRNA Vaccines Work?
Vaccines induce an immune response by delivering weakened or inactivated germs to the body but not mRNA vaccines. The mRNA vaccines use mRNA created in a laboratory to teach our cells how to make a protein, or even just a fragment of a protein, that triggers an immune response within our bodies. Immunity, which produces antibodies, protects us from becoming infected if a real virus is introduced into our bodies .
What About The Previous mRNA Vaccines?
Even though Pfizer and Moderna have developed mRNA vaccines for the prevention of COVID-19, the CCMB's mRNA vaccine technology was developed independently and without external scientific assistance. Moreover, it is not the same technology used in the mRNA vaccine developed by a pharmaceutical firm based in Pune, which is currently undergoing testing .
When Will The New mRNA Vaccine Be Available In India?
Currently, the mRNA vaccine candidate is still in the early stages of development and is undergoing preclinical trials to assess its efficacy. Due to this, the manufacturers have not stated when the vaccine will be available for purchase in the country.
How Is The New mRNA Vaccine 'Better' Than Others?
According to the scientists developing the vaccine, the indigenous nature of the vaccine, as well as the preclinical trial results, indicate that the vaccine technology could be adapted for other infectious diseases .
The technology permits quick turnaround and large-scale replication. As a result, the technology and process could be used to combat not only COVID-19 but also other diseases such as tuberculosis, malaria, and dengue.
- wellnessSome Short-Term Benefits Of Additional Booster Dose Of mRNA Vaccine In Health Workers: WHO
- wellnessNiti Aayog Releases Compendium Of Ayush Practices To Manage Covid-19
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- wellness'Heal In India': An Indian Govt Initiative To Attract More Foreign Patients
- wellnessCovid Patients At Higher Risk Of Serious Neurodegenerative Disorders: Study
- wellnessMaharashtra: Thane Records 978 New Covid-19 Cases; Active Tally At 5,634
- wellnessIndia Emerged Successfully In The Management Of Covid-19 Pandemic: Mansukh Mandaviya
- wellnessIndia Records 15,940 Covid-19 Infections, 20 Fatalities In A Day
- kidsLong COVID In Children Can Last At Least Two Months: Study
- wellnessGenome Sequencing Tests Show Omicron Dominating In Karnataka: Health Minister
- wellnessHow Does COVID Spread During Short Conversations?
- wellnessSurge In Covid Cases: States Asked To Submit 'Larger Number' Of Samples For Genome Sequencing